Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status.
Biologicals
; 37(3): 165-8, 2009 Jun.
Article
em En
| MEDLINE
| ID: mdl-19328010
ABSTRACT
The success of vaccination has remained an important contribution towards public health in both industrialised and developing countries. However, there are still unmet public health needs in vaccine preventable diseases owing to issues related to affordability, supply, public awareness, research and development, intellectual property, skilled human resource, etc. Various global initiatives are being taken to tackle such issues. DCVMN, Developing Country Vaccine Manufacturers' Network, is one of such novel initiatives by developing countries, and is playing an important role in facilitating cheaper and quality vaccines to children of the world. DCVMN has become an international body for emerging vaccine manufacturers from the developing world. This manuscript provides an overview of DCVMN with respect to its origin, objectives, achievements, limitations and expectations.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Vacinas
/
Necessidades e Demandas de Serviços de Saúde
Limite:
Humans
Idioma:
En
Revista:
Biologicals
Assunto da revista:
ALERGIA E IMUNOLOGIA
Ano de publicação:
2009
Tipo de documento:
Article
País de afiliação:
Índia